Groundbreaking G6PD diagnostic test prequalified by WHO to ensure safe malaria treatment
On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) infection.
9 Jan 18:05 · News-Medical
WHO prequalifies diagnostic test for P. vivax malaria relapse
It said each year, approximately 500,000 people die from malaria, with most of the fatalities occurring among children.
8 Jan 21:56 · Premium Times
last updated on 10 Jan 03:40